'If you only want to code without thinking about how it helps healthcare professionals, then HemoCue might not be the right company for you.' Johan Gärdsmark shares tips for prioritizing structure, transparency and purpose as a team leader. bit.ly/47SYh5O

Scientific pioneer @IDTDNA was the first U.S. company to have its primer and probe kits for COVID-19 testing approved by the CDC. IDT's key components proved to play an important role during the pandemic.

RNA-based medicines offer life-saving potential, but their manufacturing process is siloed and complex. That's why @Aldevron, Cytiva, @Moldev, and @SCIEX created a seamless mRNA production ecosystem centralized under one roof. Read more: bit.ly/3QZKMuf

In 2015, the Leica Microsystems M525 F40 microscope made history when it was used during the world's first bilateral hand transplant on a child, setting the stage for future medical advancements.

It's World Antimicrobial Resistance Awareness Week 🦠 The rise of antibiotic resistance makes common infections harder to treat. Beckman Coulter Diagnostics partners with healthcare professionals to combat this growing global #health threat. bit.ly/40uaStM

It’s a historic day for biomedicine, with the world’s first government approval of a therapy based on #CRISPR gene editing. Congratulations to all who made this milestone accomplishment possible! bbc.in/47AphHj

Most drug developers are still managing their processes with pen and paper. IDBS has modernized drug development software, helping scientists minimize admin time and focus on discovery.

From Genomes to Cures. From Insights to Impact. From Process to Patients. From Discovery to Approval. See how we bring science to life and turn innovation into impact: danaher.com/science #speedoflife #scienceday

Danaher will partner with University of Oxford to develop a precision medicine test for #sepsis , a pathological immune response to infection that accounts for one in five deaths globally each year. bit.ly/3MsVDLN

Exciting development: University of Oxford in partnership with Danaher Corporation to develop test to enable precision medicine care for #sepsis , based on research by Professor Julian Knight Knight Genetics
oxfordbrc.nihr.ac.uk/partnership-wi… Cepheid Centre for Human Genetics Nuffield Department of Medicine @Oxfordmedsci

Our Diagnostics businesses enable doctors to provide over a million cancer diagnoses every week, giving doctors more time to plan and patients more time to fight. #speedoflife

Proud to be a founding member of the Alliance for mRNA Medicines, bringing together #mRNA industry leaders, innovators, scientists and other key stakeholders to propel the future of mRNA medicine, improve patients’ lives and advance scientific knowledge. bit.ly/3FHTZCq

Announced today: Christopher Riley has been appointed Executive Vice President with responsibility for Danaher’s Biotechnology business, effective January 1, 2024. bit.ly/40n7EZ1

Associates at Cytiva are tackling single-use plastics by deploying a cold-storage shipment solution that eliminates styrofoam from secondary packaging. Our teams help build a better future for human #health and our planet. #speedoflife

Mammotome Tijuana celebrated #BCAM with several activities emphasizing early breast cancer detection, including free breast care education, an internal awareness and prevention campaign, and painting canvases symbolizing patients in the fight against breast cancer.

📢 We're excited to announce a new partnership with 10x Genomics to expand automation solutions for single cell assay workflows.

Read more in GenomeWeb: becls.co/40jaDSj

Accurate diagnoses contribute to stronger, more effective treatment plans. Our Operating Company Lauren’s instruments are used to test nearly 1 million blood samples daily around the world to make #speedoflife testing a reality.

Excited about this collaboration between Cytiva and RoosterBio to address exosome manufacturing challenges, with the ultimate goal of enabling faster adoption of promising gene therapies and other new modalities. bit.ly/3FwciKH #speedoflife

DYK: The average cost of bringing a new drug to market is a whopping $1.2B. In Technology Networks, we discuss the cost- and time-saving benefits of AI-enabled #organoid culture at scale: ow.ly/RnSu50PYoIn.

#3dbiology #AI #innovation #scienceandtechnology #drugdiscovery

Today, we announced results for the third quarter 2023. See the full release: lnkd.in/ez3bmtPU #speedoflife